None listed
Conditions
Interventions
Intervention1: Unani Formulation: Tablets (UNIM-301) Orally Twice Daily. Oil (UNIM-304) Used For Local Application UNIM-302(Pashoya) Used For Hot Fomentation On The Affected Joints
Control Interventi
Sponsors
Central council for research in Unani medicine-CCRUM
Central council for research in Unani medicine-CCRUM
Eligibility
Inclusion criteria
Inclusion criteria: Aged between 40 to 70 years Either Sex Patients diagnosed according to American College of Rheumatology Criteria for osteoarthritis of different joints will be selected Patients with symptoms consistent with osteoarthritis of the joint involved for at least six months prior to screening. Patients, who will be willing to discontinue all NSAIDs or other analgesic medication taken for any condition, will be included in the test group. Willingness to sign the informed consent, follow the protocol and participate in clinical trial voluntarily.
Exclusion criteria
Exclusion criteria: Pregnancy and Lactation Diabetes mellitus Renal dysfunction Liver diseases Gastrointestinal diseases(Peptic ulcer disease) Other types of arthritis IHD and hypertension History of surgery of the joint involved Patients who will be unable to read/or understand the WOMAC questionnaire form
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Clinical Parameters WOMAC Osteoarthritis Index Visual Analogue Scale (VAS) Active Range Of Motion (AROM)Timepoint: 1 | — |
Secondary
| Measure | Time frame |
|---|---|
| hese Parameters Will Be Done Before The Treatment And After The Completion Of The Study Lipidperoxidation Reduced Glutathione Superoxide Dismutase Catalase Radiological Parameters X Rays Of The Affected Joints Will Be Taken Before And After Treatment To Compare Radiological Changes (If Any)Timepoint: 2 | — |
Countries
India
Contacts
Public ContactDr.M.Akhtar Siddiqui
Outcome results
None listed